1887

Abstract

Summary

UC9271 mixed with dextran or gelatin microcarrier beads and injected subcutaneously into mice resulted in the formation of reproducible, sustained abscesses with as few as 2 × 10 cfu. Without microcarrier beads, 4 × 10 cfu were required to produce an abscess. The abscesses that developed with microcarriers attained a diameter of up to 1.5 cm and persisted for several days before discharging through the skin. The pH of the abscesses fell from 7.1 to 6.6 within 24 h. Histological and microscopic examination of the abscesses revealed an influx of phagocytic cells, mostly polymorphonuclear leucocytes, within 1-2 h after injection. Cell debris accumulated and the abscess became encapsulated 24-48 h after infection. Enzymatic digestion of the abscess contents allowed analysis of the host and bacterial cell populations and treatment with lysostaphin permitted differentiation between phagocytosed and free bacterial populations of . Phagocytosed but viable comprised . 50% of the total bacterial population after 24 h; however, by 96 h the phagocytosed population was only 1-5% of the total population, primarily because of an increase in extracellular bacterial numbers. Prevention of abscess formation by antibiotic treatment based upon the minimal inhibitory concentration (MIC) of an antibiotic for was not always predictable. Tetracycline did not prevent abscess formation even though it possessed a low MIC for ; methicillin had a borderline MIC value but was quite active. However, the MIC values were quite predictive of antibiotic cures in a systemic-lethal infection in mice.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-28-4-259
1989-04-01
2022-08-14
Loading full text...

Full text loading...

/deliver/fulltext/jmm/28/4/medmicro-28-4-259.html?itemId=/content/journal/jmm/10.1099/00222615-28-4-259&mimeType=html&fmt=ahah

References

  1. Actor P., Grappel S. F. 1982; Efficacy of ceftizoxime and related compounds in animal models of infection. Journal of Antimicrobial Chemotherapy 10: Suppl. C 81–89
    [Google Scholar]
  2. Bartlett J. G., Louie T. J., Gorbach S. L., Onderdonk A. B. 1981; Therapeutic efficacy of 29 antimicrobial regimens in experimental intra-abdominal sepsis. Reviews of Infectious Diseases 3:535–542
    [Google Scholar]
  3. Berti M., Rossie E., Candiani G., Arioli V. 1982; A new model of experimental Bacteroides fragilis infection in mice and rats. Chemotherapy 28:213–217
    [Google Scholar]
  4. Brook I., Coolbaugh J. C., Walker R. I. 1983; Antibiotic and clavulanic acid treatment of subcutaneous abscesses caused by Bacteroides fragilis alone or in combination with aerobic bacteria. Journal of Infectious Diseases 148:156–159
    [Google Scholar]
  5. Finney D. J. 1978; Statistical method in biological assay. 3rd edn Charles Griffin & Co. Ltd; London:
    [Google Scholar]
  6. Ford C. W., Hamel J. C., Stapert D., Yancey R. J. 1987; Antibiotic therapy for an experimental Staphylococcus epidermidis subcutaneous abscess in mice. Zentralblattfur Bakteriologie, Mikrobiologieund Hygiene Suppl 16:247–257
    [Google Scholar]
  7. Fu K. P., Lasinski E. R., Zogonas H. C., Kimble E. F., Konopka E. A. 1984; Therapeutic efficacy and pharmacokinetic properties of rifampicin in a Bacteroides fragilis intra abdominal abscess. Journal of Antimicrobial Chemotherapy 14:633–640
    [Google Scholar]
  8. Fujimoto T. 1986; Chemotherapeutic efficacy of ofloxacin on renal and subcutaneous infection models with Staphylo coccus aureus in mice. Chemotherapy 32:291–298
    [Google Scholar]
  9. Hagen J. C., Wood W. S., Hashimoto T. 1983; Experimental intraabdominal abscess formation by Escherichia coli and Bacteroidesfragilis. European Journal of Clinical Microbiology 2:43–49
    [Google Scholar]
  10. Harris R. W., Moore W. L., Arensman J. B., Rissing J. P. 1984; Antimicrobial activity of latamoxef (moxalactam) against both Bacteroides fragilis and Escherichia coli in an intraper itoneal abscess model. Journal of Antimicrobial Chemotherapy 14:499–508
    [Google Scholar]
  11. Hart P. H., Spencer L. K., Nulsen M. F., McDonald P. J., Finlay-Jones J. J. 1986; Neutrophil activity in abscess-bearing mice: comparative studies with neutrophils isolated from periph eral blood, elicited peritoneal exudates, and abscesses. Infection and Immunity 51:936–941
    [Google Scholar]
  12. Hau T., Jacobs D. E., Hawkins N. L. 1986; Antibiotics fail to prevent abscess formation secondary to bacteria trapped in fibrin clots. Archives of Surgery 121:163–168
    [Google Scholar]
  13. Hays R. C., Mandell G. L. 1974; P02, pH, and redox potential of experimental abscesses. Proceedings of the Society for Experimental Biology and Medicine 147:29–30
    [Google Scholar]
  14. Joiner K., Lowe B., Dzink J., Bartlett J. G. 1982; Comparative efficacy of 10 antimicrobial agents in experimental infec tions with Bacteroides fragilis. Journal of Infectious Diseases 145:561–568
    [Google Scholar]
  15. Joiner K. A., Onderdonk A. B., Gelfand J. A., Bartlett J. G., Gorbach S. L. 1980; A quantitative model for subcutaneous abscess formation in mice. British Journal of Experimental Pathology 61:97–107
    [Google Scholar]
  16. Kapral F. A., Godwin J. R., Dye E. S. 1980; Formation of intraperitoneal abscesses by Staphylococcus aureus. Infection and Immunity 30:204–211
    [Google Scholar]
  17. Lam G. T., Sweeney F. R., Witmer C. M., Wise R. I. 1963; Abscess forming factor(s) produced by Staphylococcus aureus I. Collodion bag implantation technique. Journal of Bacteriology 86:611–615
    [Google Scholar]
  18. McConville J. H., Snyder M. J., Calia F. M., Hornick R. B. 1981; Model of intra-abdominal abscess in mice. Infection and Immunity 31:507–509
    [Google Scholar]
  19. Nakatani T., Sato T., Manzella L., Hirai F., Trump B. F., Siegel J. H. 1984; Hepatic and systemic metabolic responses to aerobic and anaerobic intra-abdominal abscesses in a highly reproducible chronic rat model. Circulatory Shock 13:271–294
    [Google Scholar]
  20. Nulsen M. F., Finlay-Jones J. J., Skinner J. M., McDonald P. J. 1983; Intra-abdominal abscess formation in mice: quantitative studies on bacteria and abscess-potentiating agents. British Journal of Experimental Pathology 64:345–353
    [Google Scholar]
  21. Paris M. S., Eaton D. L., Sempolinski D. E., Sharma P. B. 1983; A gelatin microcarrier for cell culture. 35th Annual Meeting of the Tissue Culture Association; Orlando, FL:
    [Google Scholar]
  22. Reznikov M., McDonald P. J. 1983; Effect of metronidazole on Escherichia coli in the presence of Bacteroides fragilis: an investigation in mice. Chemotherapy 29:225–229
    [Google Scholar]
  23. Rolin O., Huet Y., Bouanchaud D. H. 1986; Comparative efficacy of pefloxacin and six other antimicrobial agents on Staphylococcus aureus experimental abscesses. Journal of Antimicrobial Chemotherapy 17: Suppl B 49–52
    [Google Scholar]
  24. Simon G. L., Richmond D. M., Tally F. P., Barza M., Gorbach S. L. 1981; Penetration of clindamycin into experimental infec tions with Bacteroides fragilis. Journal of Antimicrobial Chemotherapy 8:59–64
    [Google Scholar]
  25. Sykes R. B., Griffiths A., Ryan D. M. 1977; Comparative activity of ampicillin and cefuroxime against three types of Haemophi lus influenzae. Antimicrobial Agents and Chemotherapy 114:599–604
    [Google Scholar]
  26. Taubler J. H., Kapral F. A. 1966; Staphylococcal population changes in experimentally infected mice: infection with suture-adsorbed and unadsorbed organisms grown in vitro and in vivo. Journal of Infectious Diseases 116:257–262
    [Google Scholar]
  27. Wells C. L., Arland L. A., Simmons R. L., Rotstein O. D. 1985; In-vivo bactericidal activity of Sch 34343 in Bacteroidesfragilis abscesses and in Bacteroides fragilis-Escherichia coli abscesses. Journal of Antimicrobial Chemotherapy 15: Suppl C 199–206
    [Google Scholar]
  28. Zinner S. H., Klastersky J., Gaya H., Bernard C., Ryff J. C. 1981; In-vitro and in-vivo studies of three antibiotic combinations against gram-negative bacteria and Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 20:463–469
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-28-4-259
Loading
/content/journal/jmm/10.1099/00222615-28-4-259
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error